The ERSR is regulated by ATF6, IRE1, and PERK in normal cells [84], while it is often deregulated and promotes tumorigenicity, as the depletion of tumor suppressors or activation of oncogenes, favors cells that survive during high protein synthesis and metabolic stress in cancer cells [85]. The gene discussed is EIF2AK3; the disease is cancer.